Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.39
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
2.30
-3.77%
After-hours: Oct 03, 2025, 07:43 PM EDT
0.00% (1D)
| Bid | 2.23 |
| Market Cap | 11.47M |
| Revenue (ttm) | 70K |
| Net Income (ttm) | -7.08M |
| EPS (ttm) | -2.09 |
| PE Ratio (ttm) | -1.14 |
| Forward PE | -2.57 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.44 |
| Volume | 63,543 |
| Avg. Volume (20D) | 951,041 |
| Open | 2.44 |
| Previous Close | 2.39 |
| Day's Range | 2.35 - 2.44 |
| 52-Week Range | 0.97 - 9.79 |
| Beta | 0.89 |
| Ex-Dividend Date | n/a |
About PHIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+9.16%
Phio Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+17.14%
Phio Pharmaceuticals shares are trading higher HC Wainwright & Co. assumed a Buy rating on the stock and announced a price target of $14.
2 weeks ago · newsfilecorp.com
Phio Pharmaceuticals to Present at the Life Sciences Future ConferenceKey updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762 King of Prussia, Pennsylvania--(Newsfile Corp. - September 18, 2025) - Phio Pharmace...
